ADVM Adverum Biotechnologies Inc

USD 11.15 -0.20 -1.762115
Icon

Adverum Biotechnologies Inc (ADVM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 11.15

-0.20 (-1.76)%

USD 0.23B

0.10M

USD 4.00(-64.13%)

N/A

Icon

ADVM

Adverum Biotechnologies Inc (USD)
COMMON STOCK | NSD
USD 11.15
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.23B

N/A

USD 11.15

Adverum Biotechnologies Inc (ADVM) Stock Forecast

Show ratings and price targets of :
USD 4.00
(-64.13%)

Based on the Adverum Biotechnologies Inc stock forecast from 3 analysts, the average analyst target price for Adverum Biotechnologies Inc is USD 4.00 over the next 12 months. Adverum Biotechnologies Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Adverum Biotechnologies Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Adverum Biotechnologies Inc’s stock price was USD 11.15. Adverum Biotechnologies Inc’s stock price has changed by -6.85% over the past week, +529.94% over the past month and +22.53% over the last year.

No recent analyst target price found for Adverum Biotechnologies Inc
No recent average analyst rating found for Adverum Biotechnologies Inc

Company Overview Adverum Biotechnologies Inc

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients...Read More

https://www.adverum.com

800 Saginaw Drive, Redwood City, CA, United States, 94063

121

December

USD

USA

Adjusted Closing Price for Adverum Biotechnologies Inc (ADVM)

Loading...

Unadjusted Closing Price for Adverum Biotechnologies Inc (ADVM)

Loading...

Share Trading Volume for Adverum Biotechnologies Inc Shares

Loading...

Compare Performance of Adverum Biotechnologies Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ADVM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Adverum Biotechnologies Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.38 (+0.10%) USD107.38B 29.93 21.06

ETFs Containing ADVM

Symbol Name ADVM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Adverum Biotechnologies Inc (ADVM) Stock

Based on ratings from 3 analysts Adverum Biotechnologies Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 3 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on ADVM's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for ADVM is USD 4.00 over the next 12 months. The maximum analyst target price is USD 4 while the minimum anlayst target price is USD 4.

Unfortunately we do not have enough data on ADVM's stock to indicate if its overvalued.

The last closing price of ADVM's stock was USD 11.15.

The most recent market capitalization for ADVM is USD 0.23B.

Based on targets from 3 analysts, the average taret price for ADVM is projected at USD 4.00 over the next 12 months. This means that ADVM's stock price may go down by -64.13% over the next 12 months.

We can't find any ETFs which contains Adverum Biotechnologies Inc's stock.

As per our most recent records Adverum Biotechnologies Inc has 121 Employees.

Adverum Biotechnologies Inc's registered address is 800 Saginaw Drive, Redwood City, CA, United States, 94063. You can get more information about it from Adverum Biotechnologies Inc's website at https://www.adverum.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...